Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Recent advancements in the B7/CD28 immune checkpoint families: new biology and clinical therapeutic strategies
Marc C. Pulanco, Anne Tranberg Madsen, Ankit Tanwar, et al.
Cellular and Molecular Immunology (2023) Vol. 20, Iss. 7, pp. 694-713
Closed Access | Times Cited: 38

Showing 1-25 of 38 citing articles:

The role of PD-1 signaling in health and immune-related diseases
Ruyue Chen, Yun Zhu, Yunyan Shen, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 56
Development of pharmacological immunoregulatory anti-cancer therapeutics: current mechanistic studies and clinical opportunities
Nanhao Yin, Xintong Li, Xuanwei Zhang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 19
Programmed death receptor (PD-)1/PD-ligand (L)1 in urological cancers : the “all-around warrior” in immunotherapy
Qiang Liu, Yujing Guan, Shenglong Li
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 15
Directed Evolution of Multicyclic Peptides Using Yeast Display for Sensitive and Selective Fluorescent Analysis of CD28 on the Cell Surface
Chaoying Xu, Xiaoting Meng, Ping Chai, et al.
Analytical Chemistry (2025)
Closed Access | Times Cited: 1
An OMV‐Based Nanovaccine as Antigen Presentation Signal Enhancer for Cancer Immunotherapy
Yichao Lu, Nana Ma, Keman Cheng, et al.
Advanced Materials (2025)
Closed Access | Times Cited: 1
Anti-PD-L1-Based Bispecific Antibodies Targeting Co-Inhibitory and Co-Stimulatory Molecules for Cancer Immunotherapy
Qiaohong Geng, Peifu Jiao
Molecules (2024) Vol. 29, Iss. 2, pp. 454-454
Open Access | Times Cited: 7
Frontiers and future of immunotherapy for pancreatic cancer: from molecular mechanisms to clinical application
Rui Zheng, Xiaobin Liu, Yufu Zhang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 7
Regulatory T cells as crucial trigger and potential target for hyperprogressive disease subsequent to PD-1/PD-L1 blockade for cancer treatment
Zhe Ren, Kaiqing Yang, Lin Zhu, et al.
International Immunopharmacology (2024) Vol. 132, pp. 111934-111934
Closed Access | Times Cited: 5
PD-L1-CD80 interactions are required for intracellular signaling necessary for dendritic cell migration
Uma Kantheti, Tadg Forward, Erin D. Lucas, et al.
Science Advances (2025) Vol. 11, Iss. 5
Closed Access
New insights into cancer immune checkpoints landscape from single-cell RNA sequencing
Qian Wang, Jiahui He, Tianyu Lei, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2025) Vol. 1880, Iss. 3, pp. 189298-189298
Closed Access
Cancer Immunology and Immunotherapy
Guang-Rui Wang, Lei‐Ming Cao, Zhenyu Xu, et al.
(2025), pp. 3-18
Closed Access
Targeting B7-H3 inhibition-induced activation of fatty acid synthesis boosts anti-B7-H3 immunotherapy in triple-negative breast cancer
Ying Jiang, Zhiwen Qian, C Wang, et al.
Journal for ImmunoTherapy of Cancer (2025) Vol. 13, Iss. 4, pp. e010924-e010924
Open Access
TOP CAR with TMIGD2 as a safe and effective costimulatory domain in CAR cells treating human solid tumors
Christopher Nishimura, Devin T. Corrigan, Xiang Yu Zheng, et al.
Science Advances (2024) Vol. 10, Iss. 19
Open Access | Times Cited: 4
Design a novel of Brucellosis preventive vaccine based on IgV_CTLA-4 and multiple epitopes via immunoinformatics approach
Yueyue He, YueJie Zhu, Zhengwei Yin, et al.
Microbial Pathogenesis (2024) Vol. 195, pp. 106909-106909
Closed Access | Times Cited: 4
PI3K/AKT/mTOR and PD‑1/CTLA‑4/CD28 pathways as key targets of cancer immunotherapy (Review)
Shuangcui Wang, Changyu Liu, Chenxin Yang, et al.
Oncology Letters (2024) Vol. 28, Iss. 6
Open Access | Times Cited: 4
Single-cell atlas of the pregnant equine endometrium before and after implantation
Joanna Jaworska, Dawid Tobolski, Shireen Salem, et al.
Biology of Reproduction (2025)
Closed Access
Immunotherapy and the Tumor Microenvironment in Brain Metastases from Non-Small Cell Lung Cancer: Challenges and Future Directions
Meng Wang, Jihua Yang, S. Wang, et al.
Current Oncology (2025) Vol. 32, Iss. 3, pp. 171-171
Open Access
Cordycepin synergizes with CTLA-4 blockade to remodel the tumor microenvironment for enhanced cancer immunotherapy
Lujun Chen, Xiao Zheng, Hao Huang, et al.
International Immunopharmacology (2023) Vol. 124, pp. 110786-110786
Closed Access | Times Cited: 9
zDHHC20-driven S-palmitoylation of CD80 is required for its costimulatory function
Bin Lü, Yi-Yun Sun, Boya Chen, et al.
Acta Pharmacologica Sinica (2024) Vol. 45, Iss. 6, pp. 1214-1223
Closed Access | Times Cited: 3
The Impact of Laparoscopic Appendectomy and Open Appendectomy on B7-H3-Mediated Intrinsic Immune Response in Children with Acute Suppurative Appendicitis
Chun-Sheng Duan, Yuan Li, Jiansu Ma, et al.
Journal of Inflammation Research (2024) Vol. Volume 17, pp. 1577-1587
Open Access | Times Cited: 3
Recent advances in understanding the immune microenvironment in ovarian cancer
Jinxin Chen, Lu Yang, Yiming Ma, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3
The immune regulatory function of B7-H3 in malignancy: spotlight on the IFN-STAT1 axis and regulation of tumor-associated macrophages
Robin Park, James Yu, Moazzam Shahzad, et al.
Immunologic Research (2024) Vol. 72, Iss. 4, pp. 526-537
Closed Access | Times Cited: 2
Prognostic Value of B7H4 Expression in Patients with Solid Cancers: A Systematic Review and Meta-Analysis
Miriam Dawidowicz, Agnieszka Kula, Sylwia Mielcarska, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 9, pp. 5045-5045
Open Access | Times Cited: 2
B7H4 Role in Solid Cancers: A Review of the Literature
Miriam Dawidowicz, Anna Kot, Sylwia Mielcarska, et al.
Cancers (2024) Vol. 16, Iss. 14, pp. 2519-2519
Open Access | Times Cited: 2
MicroRNA-486-3p affects cisplatin resistance in high-grade serous ovarian cancer by regulating TMIGD2: An experimental study
Jing Wang, Yanan Wu
Heliyon (2024) Vol. 10, Iss. 15, pp. e34978-e34978
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top